In PNAS this week: DNA vaccine-based approach for Duchenne muscular dystrophy tested in mice, antimicrobial found in bear saliva, and more.
In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.
The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.
Spark Therapeutics reports new data on its investigational hemophilia A treatment that says it reduces bleeds, according to Stat News.
Stat News reports federal regulators have halted Sarepta Therapeutics' Duchenne muscular dystrophy gene therapy trial.
Business Insider writes that pharmaceutical companies' interest in gene therapies has been piqued.
Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.
A new study of a β-thalassemia gene therapy appears promising, according to NPR.
Advances in gene therapy and other fields could aid in protecting astronauts from the effects of radiation, the Guardian says.
Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.
Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.
Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.
The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.
In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.
